首页> 外文期刊>Clinical and experimental hypertension: CEH >Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via beta(3) adrenoceptor-mediated mechanism
【24h】

Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via beta(3) adrenoceptor-mediated mechanism

机译:奈必洛尔通过β(3)肾上腺素受体介导的机制改善大鼠主动脉中的不对称二甲基精氨酸诱导的血管反应

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, induces endothelial dysfunction. Nebivolol, a highly selective beta(1)-adrenergic receptor (AR) blocker, is the only beta-blocker known to induce vascular production of nitric oxide. Objective: The present study was designed to evaluate the effect and mechanism of nebivolol on ADMA-induced vascular response in rat aorta in vitro. Methods: In vitro, the effects of nebivolol and ADMA on resting tone or contraction induced by phenylephrine (PE, 10(-6 )mol/L) and relaxation induced by acetylcholine (Ach, 10(-10)-10(-5 )mol/L) were evaluated. Results: ADMA in a concentration-dependent manner increased the resting and PE-induced tone and reduced Ach-induced relaxation. Nebivolol inhibited the ADMA-induced enhancements in tone and reversed the effects of ADMA on Ach-induced relaxation. These effects of nebivolol were blocked by selective beta(3) receptor blocker cyanopindolol (1 mu M), but not by selective beta(2) receptor blocker butoxamine (50 mu M). Conclusions: Nebivolol ameliorates the ADMA-induced vascular responses in rat aorta, at least in part, by mechanisms involving beta(3) adrenoceptor.
机译:背景:不对称二甲基精氨酸(ADMA)是一种内源性一氧化氮合酶(NOS)抑制剂,可引起内皮功能障碍。 Nebivolol是一种高度选择性的β(1)-肾上腺素能受体(AR)阻滞剂,是已知的诱导血管生成一氧化氮的唯一β受体阻滞剂。目的:本研究旨在评估奈必洛尔对ADMA诱导的大鼠主动脉血管反应的影响及其机制。方法:在体外,奈必洛尔和ADMA对去氧肾上腺素(PE,10(-6)mol / L)引起的静息音或收缩和乙酰胆碱(Ach,10(-10)-10(-5))引起的松弛的影响mol / L)进行评估。结果:ADMA以浓度依赖性方式增加了静息和PE诱导的语调,并减少了Ach诱导的松弛。奈比洛尔抑制ADMA诱导的音调增强,并逆转ADMA对Ach诱导的松弛的影响。 nebivolol的这些作用被选择性β(3)受体阻断剂氰基吲哚醇(1μM)阻断,但未被选择性β(2)受体阻断剂丁氧胺(50μM)阻断。结论:奈必洛尔至少部分地通过涉及β(3)肾上腺素受体的机制改善了ADMA诱导的大鼠主动脉血管反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号